J. Michael Dixon

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

Robert E. Mansel, Lesley Fallowfield, Mark Kissin et al. · JNCI Journal of the National Cancer Institute · 2006 · 1.7K citations

Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial

Ian E. Smith, Mitch Dowsett, S. Ebbs et al. · Journal of Clinical Oncology · 2005 · 767 citations · Full text

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

José Baselga, Peter van Dam, Alexey Manikhas et al. · Journal of Clinical Oncology · 2009 · 658 citations

Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer

Anne Fleissig, Lesley Fallowfield, C. Langridge et al. · Breast Cancer Research and Treatment · 2005 · 493 citations

Surgical Oncology, Breast Oncology, Early Breast Cancer +9

Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer

Mitch Dowsett, Ian E. Smith, Steve R. Ebbs et al. · Clinical Cancer Research · 2006 · 146 citations